NEW PLANTS NOT THE ANSWER TO FLU PANDEMIC SAYS STUDY

Moving from egg-based production of vaccines to the use of cell-culture technologies in existing manufacturing plants is cheaper and quicker than building new facilities to handle a flu pandemic within the next five years, new research suggests. Outsourcing-Pharma (http://www.outsourcing-pharma.com/news/ng.asp?n=70781-novartis-medimmune-cell-culture-avian-influenza)